Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder

David Ginsberg*, Tim Schneider, Con Kelleher, Philip Van Kerrebroeck, Steven Swift, Dana Creanga, Diane L. Martire

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Web of Science)
Original languageEnglish
Pages (from-to)373-385
JournalBJU International
Issue number3
Publication statusPublished - Aug 2013


  • antimuscarinic
  • fesoterodine
  • gender
  • health-related quality of life
  • overactive bladder
  • tolterodine

Cite this